This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, S. L.
Right arrow Articles by Münger, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, S. L.
Right arrow Articles by Münger, K.

 Previous Article  |  Next Article 

Journal of Virology, August 2001, p. 7583-7591, Vol. 75, No. 16
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.16.7583-7591.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7

Sonia L. Gonzalez,1,2 Matt Stremlau,3 Xi He,4 John R. Basile,2,5 and Karl Münger1,2,3,4,*

Program in Biological Sciences in Public Health, Harvard School of Public Health,1 Program in Biological and Biomedical Sciences,3 Virology Program,4 and Department of Pathology,2 Harvard Medical School, and Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine,5 Boston, Massachusetts 02115

Received 23 February 2001/Accepted 8 May 2001

The steady-state level and metabolic half-life of retinoblastoma tumor suppressor protein pRB are decreased in cells that express high-risk human papillomavirus (HPV) E7 proteins. Here we show that pRB degradation is a direct activity of E7 and does not reflect a property of cell lines acquired during the selection process for E7 expression. An amino-terminal domain of E7 that does not directly contribute to pRB binding but is required for transformation is also necessary for E7-mediated pRB degradation. Treatment with inhibitors of the 26S proteasome not only blocks E7-mediated pRB degradation but also causes the stabilization of E7. Mutagenic analyses, however, reveal that the processes of proteasomal degradation of E7 and pRB are not linked processes. HPV type 16 E7 also targets the pRB-related proteins p107 and p130 for destabilization by a proteasome-dependent mechanism. Using the SAOS2 flat-cell assay as a biological indicator for pRB function, we demonstrate that pRB degradation, not solely binding, is important for the E7-induced inactivation of pRB.


* Corresponding author. Mailing address: Department of Pathology and Center for Cancer Research, Harvard Medical School, Armenise Research Building D2/544A, 200 Longwood Ave., Boston, MA 02115-5701. Phone: (617) 432-2878. Fax: (617) 432-0426. E-mail: karl_munger{at}hms.harvard.edu.


Journal of Virology, August 2001, p. 7583-7591, Vol. 75, No. 16
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.16.7583-7591.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kelley-Clarke, B., De Leon-Vazquez, E., Slain, K., Barbera, A. J., Kaye, K. M. (2009). Role of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal LANA Chromosome Binding in Episome Persistence. J. Virol. 83: 4326-4337 [Abstract] [Full Text]  
  • Wang, X., Wang, H.-K., McCoy, J. P., Banerjee, N. S., Rader, J. S., Broker, T. R., Meyers, C., Chow, L. T., Zheng, Z.-M. (2009). Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15: 637-647 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Mintz-Cole, R. A., Morris, T. A., Simpson, D. S., Wikenheiser-Brokamp, K. A., Currier, M. A., Cripe, T. P., Grosveld, G. C., Wells, S. I. (2009). Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo. Cancer Res. 69: 1792-1799 [Abstract] [Full Text]  
  • Jia, R., Liu, X., Tao, M., Kruhlak, M., Guo, M., Meyers, C., Baker, C. C., Zheng, Z.-M. (2009). Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20. J. Virol. 83: 167-180 [Abstract] [Full Text]  
  • Yoshida, S., Kajitani, N., Satsuka, A., Nakamura, H., Sakai, H. (2008). Ras Modifies Proliferation and Invasiveness of Cells Expressing Human Papillomavirus Oncoproteins. J. Virol. 82: 8820-8827 [Abstract] [Full Text]  
  • Le Rouzic, E., Morel, M., Ayinde, D., Belaidouni, N., Letienne, J., Transy, C., Margottin-Goguet, F. (2008). Assembly with the Cul4A-DDB1DCAF1 Ubiquitin Ligase Protects HIV-1 Vpr from Proteasomal Degradation. J. Biol. Chem. 283: 21686-21692 [Abstract] [Full Text]  
  • Caberg, J.-H. D., Hubert, P. M., Begon, D. Y., Herfs, M. F., Roncarati, P. J., Boniver, J. J., Delvenne, P. O. (2008). Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis 29: 1441-1447 [Abstract] [Full Text]  
  • Darnell, G. A., Schroder, W. A., Antalis, T. M., Lambley, E., Major, L., Gardner, J., Birrell, G., Cid-Arregui, A., Suhrbier, A. (2007). Human Papillomavirus E7 Requires the Protease Calpain to Degrade the Retinoblastoma Protein. J. Biol. Chem. 282: 37492-37500 [Abstract] [Full Text]  
  • Nguyen, C. L., Eichwald, C., Nibert, M. L., Munger, K. (2007). Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component {gamma}-Tubulin. J. Virol. 81: 13533-13543 [Abstract] [Full Text]  
  • Huh, K., Zhou, X., Hayakawa, H., Cho, J.-Y., Libermann, T. A., Jin, J., Wade Harper, J., Munger, K. (2007). Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor. J. Virol. 81: 9737-9747 [Abstract] [Full Text]  
  • Schweiger, M.-R., Ottinger, M., You, J., Howley, P. M. (2007). Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins. J. Virol. 81: 9612-9622 [Abstract] [Full Text]  
  • Lu, Z. H., Wright, J. D., Belt, B., Cardiff, R. D., Arbeit, J. M. (2007). Hypoxia-Inducible Factor-1 Facilitates Cervical Cancer Progression in Human Papillomavirus Type 16 Transgenic Mice. Am. J. Pathol. 171: 667-681 [Abstract] [Full Text]  
  • Rehtanz, M., Ghim, S.-j., Rector, A., Van Ranst, M., Fair, P. A., Bossart, G. D., Jenson, A. B. (2006). Isolation and characterization of the first American bottlenose dolphin papillomavirus: Tursiops truncatus papillomavirus type 2. J. Gen. Virol. 87: 3559-3565 [Abstract] [Full Text]  
  • Balsitis, S., Dick, F., Dyson, N., Lambert, P. F. (2006). Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis. Cancer Res. 66: 9393-9400 [Abstract] [Full Text]  
  • Oh, K.-J., Kalinina, A., Park, N.-H., Bagchi, S. (2006). Deregulation of eIF4E: 4E-BP1 in Differentiated Human Papillomavirus-Containing Cells Leads to High Levels of Expression of the E7 Oncoprotein. J. Virol. 80: 7079-7088 [Abstract] [Full Text]  
  • Tang, S., Tao, M., McCoy, J. P. Jr., Zheng, Z.-M. (2006). The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation. J. Virol. 80: 4249-4263 [Abstract] [Full Text]  
  • Zhang, B., Chen, W., Roman, A. (2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. USA 103: 437-442 [Abstract] [Full Text]  
  • Knight, J. S., Sharma, N., Robertson, E. S. (2005). Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc. Natl. Acad. Sci. USA 102: 18562-18566 [Abstract] [Full Text]  
  • Munakata, T., Nakamura, M., Liang, Y., Li, K., Lemon, S. M. (2005). Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA 102: 18159-18164 [Abstract] [Full Text]  
  • Collins, A. S., Nakahara, T., Do, A., Lambert, P. F. (2005). Interactions with Pocket Proteins Contribute to the Role of Human Papillomavirus Type 16 E7 in the Papillomavirus Life Cycle. J. Virol. 79: 14769-14780 [Abstract] [Full Text]  
  • Balsitis, S., Dick, F., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N., Lambert, P. F. (2005). Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo. J. Virol. 79: 11392-11402 [Abstract] [Full Text]  
  • Huh, K.-W., DeMasi, J., Ogawa, H., Nakatani, Y., Howley, P. M., Munger, K. (2005). Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. USA 102: 11492-11497 [Abstract] [Full Text]  
  • Kelley, M. L., Keiger, K. E., Lee, C. J., Huibregtse, J. M. (2005). The Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase. J. Virol. 79: 3737-3747 [Abstract] [Full Text]  
  • Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., Huh, K. (2004). Mechanisms of Human Papillomavirus-Induced Oncogenesis. J. Virol. 78: 11451-11460 [Full Text]  
  • Oh, K.-J., Kalinina, A., Wang, J., Nakayama, K., Nakayama, K. I., Bagchi, S. (2004). The Papillomavirus E7 Oncoprotein Is Ubiquitinated by UbcH7 and Cullin 1- and Skp2-Containing E3 Ligase. J. Virol. 78: 5338-5346 [Abstract] [Full Text]  
  • Psyrri, A., DeFilippis, R. A., Edwards, A. P. B., Yates, K. E., Manuelidis, L., DiMaio, D. (2004). Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells. Cancer Res. 64: 3079-3086 [Abstract] [Full Text]  
  • Patel, D., Incassati, A., Wang, N., McCance, D. J. (2004). Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins. Cancer Res. 64: 1299-1306 [Abstract] [Full Text]  
  • Balsitis, S. J., Sage, J., Duensing, S., Munger, K., Jacks, T., Lambert, P. F. (2003). Recapitulation of the Effects of the Human Papillomavirus Type 16 E7 Oncogene on Mouse Epithelium by Somatic Rb Deletion and Detection of pRb-Independent Effects of E7 In Vivo. Mol. Cell. Biol. 23: 9094-9103 [Abstract] [Full Text]  
  • Tao, M., Kruhlak, M., Xia, S., Androphy, E., Zheng, Z.-M. (2003). Signals That Dictate Nuclear Localization of Human Papillomavirus Type 16 Oncoprotein E6 in Living Cells. J. Virol. 77: 13232-13247 [Abstract] [Full Text]  
  • Duensing, S., Munger, K. (2003). Human Papillomavirus Type 16 E7 Oncoprotein Can Induce Abnormal Centrosome Duplication through a Mechanism Independent of Inactivation of Retinoblastoma Protein Family Members. J. Virol. 77: 12331-12335 [Abstract] [Full Text]  
  • He, W., Staples, D., Smith, C., Fisher, C. (2003). Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7. J. Virol. 77: 10566-10574 [Abstract] [Full Text]  
  • Kalejta, R. F., Bechtel, J. T., Shenk, T. (2003). Human Cytomegalovirus pp71 Stimulates Cell Cycle Progression by Inducing the Proteasome-Dependent Degradation of the Retinoblastoma Family of Tumor Suppressors. Mol. Cell. Biol. 23: 1885-1895 [Abstract] [Full Text]  
  • von Willebrand, M., Zacksenhaus, E., Cheng, E., Glazer, P., Halaban, R. (2003). The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells. Cancer Res. 63: 1420-1429 [Abstract] [Full Text]  
  • Caldeira, S., Zehbe, I., Accardi, R., Malanchi, I., Dong, W., Giarre, M., de Villiers, E.-M., Filotico, R., Boukamp, P., Tommasino, M. (2003). The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties. J. Virol. 77: 2195-2206 [Abstract] [Full Text]  
  • Helt, A.-M., Galloway, D. A. (2003). Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24: 159-169 [Abstract] [Full Text]  
  • Piboonniyom, S.-o., Duensing, S., Swilling, N. W., Hasskarl, J., Hinds, P. W., Munger, K. (2003). Abrogation of the Retinoblastoma Tumor Suppressor Checkpoint During Keratinocyte Immortalization Is Not Sufficient for Induction of Centrosome-mediated Genomic Instability. Cancer Res. 63: 476-483 [Abstract] [Full Text]  
  • Zhao, L., Samuels, T., Winckler, S., Korgaonkar, C., Tompkins, V., Horne, M. C., Quelle, D. E. (2003). Cyclin G1 Has Growth Inhibitory Activity Linked to the ARF-Mdm2-p53 and pRb Tumor Suppressor Pathways. Mol Cancer Res 1: 195-206 [Abstract] [Full Text]  
  • Lee, D. K., Kim, B.-C., Kim, I. Y., Cho, E.-a., Satterwhite, D. J., Kim, S.-J. (2002). The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-beta Signaling by Blocking Binding of the Smad Complex to Its Target Sequence. J. Biol. Chem. 277: 38557-38564 [Abstract] [Full Text]  
  • Helt, A.-M., Funk, J. O., Galloway, D. A. (2002). Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells. J. Virol. 76: 10559-10568 [Abstract] [Full Text]  
  • Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3. Mol. Cell. Biol. 22: 5801-5812 [Abstract] [Full Text]  
  • Dick, F. A., Dyson, N. J. (2002). Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins. J. Virol. 76: 6224-6234 [Abstract] [Full Text]  
  • Noya, F., Chien, W.-M., Wu, X., Banerjee, N. S., Kappes, J. C., Broker, T. R., Chow, L. T. (2002). The Promoter of the Human Proliferating Cell Nuclear Antigen Gene Is Not Sufficient for Cell Cycle-dependent Regulation in Organotypic Cultures of Keratinocytes. J. Biol. Chem. 277: 17271-17280 [Abstract] [Full Text]  
  • Botos, J., Smith, R. III, Kochevar, D. T. (2002). Retinoblastoma Function Is a Better Indicator of Cellular Phenotype in Cultured Breast Adenocarcinoma Cells than Retinoblastoma Expression. Exp. Biol. Med. 227: 354-362 [Abstract] [Full Text]